Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
NATIONAL INSTITUTES OF HEALTH has floated a tender for Blueprint Neurotherapeutics Network (Bpn): Biologic-Based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional). The project location is USA and the tender is closing on 05 Apr 2024. The tender notice number is PAR-21-233, while the TOT Ref Number is 52537039. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : USA
Summary : Blueprint Neurotherapeutics Network (Bpn): Biologic-Based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
Deadline : 05 Apr 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 52537039
Document Ref. No. : PAR-21-233
Competition : ICB
Financier : Self Financed
Purchaser Ownership : -
Tender Value : Refer Document
Purchaser's Detail
Purchaser : NATIONAL INSTITUTES OF HEALTH
NIH OER Webmastergrantsinfo@nih.gov
USA
Email :grantsinfo@nih.gov
Tender Details
Tender are invited for Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
CFDA Number : 93.121 -- Oral Diseases and Disorders Research93.213 -- Research and Training in Complementary and Integrative Health93.242 -- Mental Health Research Grants93.273 -- Alcohol Research Programs93.279 -- Drug Abuse and Addiction Research Programs93.286 -- Discovery and Applied Research for Technological Innovations to Improve Human Health93.853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders93.865 -- Child Health and Human Development Extramural Research93.866 -- Aging Research93.867 -- Vision Research
Cost Sharing or Matching Requirement : No
Closing Date for Applications: Apr 05, 2024
Posted Date : Apr 23, 2021
Description: The Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) provides support for biologic-based therapeutic discovery and development, from lead optimization through phase I clinical testing. This Funding Opportunity Announcement (FOA) supports preclinical discovery and development of potential therapeutic Biotechnology Products and Biologics including, but not limited to, large biologic macromolecules, (e.g., proteins, antibodies, and peptides), gene-based therapies (i.e., oligonucleotide- and viral-based), cell therapies, and novel emerging therapies (e.g., microbial and ...
Documents
Want To Bid in This Tender?
Get Local Agent Support in USA and 60 More Countries.
View Tenders By
Sign in with Google